StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.10+0.05 (+0.71%)

Close on Nov 18, 2026Market cap $195.97MP/E –Yield –

Precision BioSciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Precision BioSciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$51.90M. For fiscal 2025 it was -$65.84M. The highest annual figure on record is -$10.85M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$65.84M–
FY2024Dec 31, 2024-$58.45M–
FY2023Dec 31, 2023-$84.11M–
FY2022Dec 31, 2022-$45.75M–
FY2021Dec 31, 2021-$10.85M–
FY2020Dec 31, 2020-$87.39M–
FY2019Dec 31, 2019-$71.02M–
FY2018Dec 31, 2018-$51.72M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$13.44M–
Q1 FY2026Mar 31, 2026-$11.94M–
Q4 FY2025Dec 31, 2025-$11.25M–
Q3 FY2025Sep 30, 2025-$15.27M–
Q2 FY2025Jun 30, 2025-$20.27M–
Q1 FY2025Mar 31, 2025-$19.05M–
Q4 FY2024Dec 31, 2024-$18.68M–
Q3 FY2024Sep 30, 2024-$5.91M–
Q2 FY2024Jun 30, 2024-$14.87M–
Q1 FY2024Mar 31, 2024-$18.98M–
Q4 FY2023Dec 31, 2023-$8.42M–
Q3 FY2023Sep 30, 2023-$23.09M-179.1%
Q2 FY2023Jun 30, 2023-$21.13M–
Q1 FY2023Mar 31, 2023-$31.46M–
Q4 FY2022Dec 31, 2022-$21.84M–
Q3 FY2022Sep 30, 2022$29.19M–
Q2 FY2022Jun 30, 2022-$24.22M–
Q1 FY2022Mar 31, 2022-$28.87M-142.4%
Q4 FY2021Dec 31, 2021-$23.68M–
Q3 FY2021Sep 30, 2021-$23.91M–
Q2 FY2021Jun 30, 2021-$31.34M–
Q1 FY2021Mar 31, 2021$68.07M–
Q4 FY2020Dec 31, 2020-$13.45M–
Q3 FY2020Sep 30, 2020-$22.22M–
Q2 FY2020Jun 30, 2020-$25.80M–
Q1 FY2020Mar 31, 2020-$25.91M–
Q4 FY2019Dec 31, 2019-$20.56M–
Q3 FY2019Sep 30, 2019-$13.98M–
Q2 FY2019Jun 30, 2019-$16.58M–
Q1 FY2019Mar 31, 2019-$19.91M–
Q4 FY2018Dec 31, 2018-$12.91M–
Q3 FY2018Sep 30, 2018-$15.05M–
Q2 FY2018Jun 30, 2018-$9.31M–
Q1 FY2018Mar 31, 2018-$14.45M–

More Precision BioSciences figures

See a number that looks wrong?